Bluebird bio went public in 2013, raising approximately $116m through its IPO. The company has developed three US Food and ...

Cash-strapped gene-therapy company Bluebird bio agreed to be acquired by private-equity firms Carlyle Group and SK Capital Partners in a deal potentially worth up to $96 million.

The Carlyle Group and SK Capital Partners have agreed to acquire bluebird bio, Inc, a Somerville, Massachusetts-based gene therapy firm, in a take-private deal. According to terms of the agreement, ...

SOMERVILLE, Mass., February 21, 2025--bluebird bio, Inc. (NASDAQ: BLUE) ("bluebird") today announced that it has entered into a definitive agreement to be acquired by funds managed by global ...

Kwak Noh-jung, chief executive officer (CEO) of SK hynix Inc., has emphasized the company's responsibility in South Korea's ...

You can watch the Champions League last-16 draw on the BBC Sport website and app on Friday, 21 February from 11:00 GMT, and ...

While the offseason may not have seen some of the splashy moves of the recent past, Major League Soccer clubs did add some ...

UBS Group started coverage on shares of SK Telecom (NYSE:SKM – Free Report) in a research report released on Wednesday, Marketbeat Ratings reports. The firm issued a buy rating on the Wireless ...

Ryan Flamingo scored an extra-time winner as PSV Eindhoven produced a superb performance against Juventus to overturn their first-leg deficit and book a spot in the last 16 of the ...

Samsung Electronics and SK hynix are experiencing strong gains. This is interpreted as the impact of the 'K-Chips Act,' which ...